Treatment with the mTOR inhibitor temsirolimus significantly inhibited the activation of mTOR effectors and reduced ESCC cell proliferation [135]; everolimus significantly inhibited angiotensin II-induced ESCC cell proliferation [136]. The gene discussed is MTOR; the disease is esophageal squamous cell carcinoma.